Halozyme Therapeutics issued a press release providing an update on a decision by the European Patent Office regarding a co-formulation patent for DARZALEX and reaffirming revenue guidance for 2023 and beyond.
AI Assistant
HALOZYME THERAPEUTICS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.